In light of these observations suggesting a novel function for A20 in the modulation of fibrotic responses in stromal cells, here we sought to explore the expression of A20, its regulation and function in fibroblasts, and its potential pathogenic role in human SSc and preclinical disease models. This evidence concerns the gene TNFAIP3 and systemic sclerosis.